Relationship of Proprioception, Reaction Time and the Gait and Balance Parameters After Stroke
Launched by UNIVERSITY OF RZESZOW · Dec 17, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how problems with proprioception, which is our body's ability to sense where we are in space, affect walking, balance, and reaction times in people who have had a stroke. Researchers want to understand whether these sensory issues are linked to how well stroke survivors can move and maintain their balance. They will also look at whether factors like how long it's been since the stroke, which side of the brain was affected, and the person's gender make a difference in these abilities.
To participate in the study, individuals should be between 30 and 75 years old and have had their first stroke within the last three months, resulting in weakness on one side of their body. They should be able to walk without any support. Participants will undergo a one-time assessment using standard tests and rehabilitation tools to measure their balance and movement. This study aims to compare the experiences of stroke survivors with healthy individuals to see how proprioception and reaction times differ.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • informed and voluntary consent of the patient,
- • first-time stroke,
- • hemiparesis,
- • time from stroke to 3 months,
- • age 30-75,
- • grade 3-5 in the Functional Ambulation Category,
- • walking without orthopedic support.
- Exclusion Criteria:
- • lack of informed and voluntary consent of the patient,
- • second or subsequent stroke,
- • stroke of the brainstem and cerebellum,
- • epilepsy,
- • disorders of higher mental functions,
- • coexisting neurological, rheumatological, orthopedic diseases,
- • use of orthopedic supplies during locomotion.
About University Of Rzeszow
The University of Rzeszow is a leading academic institution dedicated to advancing research and education in the health sciences. With a robust commitment to clinical research, the university actively sponsors innovative clinical trials aimed at enhancing medical knowledge and improving patient outcomes. Leveraging a multidisciplinary approach, the university collaborates with healthcare professionals, researchers, and industry partners to investigate novel therapies and interventions. Through its state-of-the-art facilities and expertise, the University of Rzeszow strives to contribute significantly to the development of evidence-based practices in medicine, fostering a healthier future for communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rzeszów, Podkarpackie, Poland
Patients applied
Trial Officials
Maciej Kochman, Dr.
Principal Investigator
Institute of Health Sciences, College of Medical Sciences, University of Rzeszów
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported